Skip to main content
. 2022 Apr;63(2):176–185. doi: 10.3325/cmj.2022.63.176

Table 1.

Characteristics of included studies that assessed the risk of death in patients with hepatocellular carcinoma*

Ref. First author Year City Country Study period Design N Therapy T2DM N events No T2DM N events
17
Toyoda
2001
Ogaki
Japan
Jan 1990-Jun 1999
Retro
581
Mix
92
39
489
209
18
Poon
2002
Hong Kong
China
Jan 1989-Sep 1999
Retro
525
HR
62
29
463
229
19
Li
2003
Beijing
China
Jan 1998-Dec 2001
Retro
225
No surg
28
10
197
63
20
Huo
2004
Taipei
Taiwan
Apr 1996-March 2001
Retro
255
HR
41
23
214
85
312
No surg
79
39
233
85
21
Komura
2007
Ishikawa
Japan
Jun 1987-May 2004
Retro
90
HR
30
17
60
14
22
Sumie
2007
Fukuoka
Japan
Jan 1994-Dec 2000
Retro
118
Mix
39
22
79
34
23
Kawamura
2008
Tokyo
Japan
Jan 1980-Dec 2006
Retro
40
HR/RFA
18
6
22
7
24
Huo
2009
Taipei
Taiwan
Jan 2002-Dec 2008
Retro
1713
Mix
392
235
1321
674
25
Feng
2010
Tainan City
Taiwan
Aug 2007-Jun 2008
Retro
52
TACE
14
2
38
6
26
Chen
2011
Taichung
Taiwan
Jul 2003-Jun 2009
Retro
135
RFA
53
26
82
19
28
Shau
2012
Taipei
Taiwan
Jan 2003-Dec 2004
Retro
931
Mix
185
96
746
248
29
Ting
2012
Taipei
Taiwan
Jan 2000-Dec 2008
Retro
389
HR
117
59
272
106
30
Hosokawa
2013
Tokyo
Japan
Jan 1999-Dec 2007
Retro
344
RFA
159
19
185
12
31
Bhat
2014
Rochester
USA
Jan 2005-Jun 2011
Retro
701
NA
263
170
438
257
32
Masood
2014
Lahore
Pakistan
Jun 2006-Dec 2012
Retro
282
Mix
97
50
185
95
33
Tsai
2014
Taichung
Taiwan
Jan 2000- Dec 2010
Retro
5924
HR
2962
41
2962
35
34
Wang
2014
Nanning
China
Jun 2003-Feb 2011
Retro
505
HR
134
1
371
8
35
Zhang
2014
Wuhan
China
Mar2002-Aug 2012
Retro
138
TACE
34
34
104
102
36
Chan
2016
Taipei
Taiwan
Jan 1995-Dec 2011
Retro
26 267
HR
6663
3929
19 604
10 183
91 482
No surg
21 449
18 931
70 034
61 539
39
Yoshida
2017
Tokyo
Japan
Jan 2001-Dec 2013
Retro
224
HR
112
41
112
33
40
Li
2018
Hangzhou
China
Jan 2008-Dec 2015
Retro
11 048
LT
3136
760
7912
1730
41
Liu
2018
Beijing
China
Jan 2005-Dec 2012
Retro
308
RFA
64
34
244
172
43
Liu
2020
Shanghai
China
Apr 2011-Jan 2017
Retro
1052
TACE
289
161
763
379
Total - - - - - - 144 566 - 36 689 24 815 107 877 25 957

*Abbreviations: Ref – reference; N – number; T2DM – type 2 diabetes mellitus; retro – retrospective; HR – hepatic resection; RFA – radiofrequency ablation; TACE – trans-arterial chemo-embolization; LT – liver transplantation.